Regulatory T Cells: From Discovery to Autoimmunity

Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a029041. doi: 10.1101/cshperspect.a029041.

Abstract

Multiple sclerosis (MS) is a genetically mediated autoimmune disease of the central nervous system. Allelic variants lead to lower thresholds of T-cell activation resulting in activation of autoreactive T cells. Environmental factors, including, among others, diet, vitamin D, and smoking, in combination with genetic predispositions, play a substantial role in disease development and activation of autoreactive T cells. FoxP3+ regulatory T cells (Tregs) have emerged as central in the control of autoreactive T cells. A consistent finding in patients with MS is defects in Treg cell function with reduced suppression of effector T cells and production of proinflammatory cytokines. Emerging data suggests that functional Tregs become effector-like T cells with loss of function associated with T-bet expression and interferon γ (IFN-γ) secretion.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmunity / immunology*
  • Cytokines / immunology*
  • Forkhead Transcription Factors
  • Humans
  • Interferon-gamma / immunology
  • Lymphocyte Activation
  • Mice
  • Multiple Sclerosis / immunology*
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Cytokines
  • Forkhead Transcription Factors
  • Interferon-gamma